BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21557953)

  • 1. Mouse models of genetic effects on cognition: relevance to schizophrenia.
    Papaleo F; Lipska BK; Weinberger DR
    Neuropharmacology; 2012 Mar; 62(3):1204-20. PubMed ID: 21557953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility genes for schizophrenia: characterisation of mutant mouse models at the level of phenotypic behaviour.
    O'Tuathaigh CM; Babovic D; O'Meara G; Clifford JJ; Croke DT; Waddington JL
    Neurosci Biobehav Rev; 2007; 31(1):60-78. PubMed ID: 16782199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular genetics of cognitive deficit in schizophrenia].
    Golimbet VE
    Mol Biol (Mosk); 2008; 42(5):830-9. PubMed ID: 18988532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
    Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms.
    Begemann M; Grube S; Papiol S; Malzahn D; Krampe H; Ribbe K; Friedrichs H; Radyushkin KA; El-Kordi A; Benseler F; Hannke K; Sperling S; Schwerdtfeger D; Thanhäuser I; Gerchen MF; Ghorbani M; Gutwinski S; Hilmes C; Leppert R; Ronnenberg A; Sowislo J; Stawicki S; Stödtke M; Szuszies C; Reim K; Riggert J; Eckstein F; Falkai P; Bickeböller H; Nave KA; Brose N; Ehrenreich H
    Arch Gen Psychiatry; 2010 Sep; 67(9):879-88. PubMed ID: 20819981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of Disrupted-In-Schizophrenia-1 (DISC1): neurodevelopment, cognition, and mental conditions.
    Ishizuka K; Paek M; Kamiya A; Sawa A
    Biol Psychiatry; 2006 Jun; 59(12):1189-97. PubMed ID: 16797264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroimaging-genetic paradigms: a new approach to investigate the pathophysiology and treatment of cognitive deficits in schizophrenia.
    Roffman JL; Weiss AP; Goff DC; Rauch SL; Weinberger DR
    Harv Rev Psychiatry; 2006; 14(2):78-91. PubMed ID: 16603474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic effects of repeated psychosocial stress during adolescence in mice mutant for the schizophrenia risk gene neuregulin-1: a putative model of gene × environment interaction.
    Desbonnet L; O'Tuathaigh C; Clarke G; O'Leary C; Petit E; Clarke N; Tighe O; Lai D; Harvey R; Cryan JF; Dinan TG; Waddington JL
    Brain Behav Immun; 2012 May; 26(4):660-71. PubMed ID: 22426432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment in schizophrenia: a review of developmental and genetic models, and pro-cognitive profile of the optimised D(3) > D(2) antagonist, S33138.
    Millan MJ; Brocco M
    Therapie; 2008; 63(3):187-229. PubMed ID: 18718210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognition in female transmembrane domain neuregulin 1 mutant mice.
    Chesworth R; Downey L; Logge W; Killcross S; Karl T
    Behav Brain Res; 2012 Jan; 226(1):218-23. PubMed ID: 21944941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene models of schizophrenia: DISC1 mouse models.
    Jaaro-Peled H
    Prog Brain Res; 2009; 179():75-86. PubMed ID: 20302820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schizophrenia: genetics, prevention and rehabilitation.
    Olgiati P; Mandelli L; Lorenzi C; Marino E; Adele P; Ferrari B; De Ronchi D; Serretti A
    Acta Neuropsychiatr; 2009 Jun; 21(3):109-20. PubMed ID: 26953749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular genetics of cognition: dopamine, COMT and BDNF.
    Savitz J; Solms M; Ramesar R
    Genes Brain Behav; 2006 Jun; 5(4):311-28. PubMed ID: 16716201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant models for genes associated with schizophrenia.
    Desbonnet L; Waddington JL; O'Tuathaigh CM
    Biochem Soc Trans; 2009 Feb; 37(Pt 1):308-12. PubMed ID: 19143653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Schizophrenia and cognition: a neurodevelopmental approach].
    Da Fonseca D; Rosset D; Bat F; Campredon S; Rouviere N; Givaudan M; Fakra E; Azorin JM; Poinso F
    Encephale; 2011 Dec; 37 Suppl 2():S133-6. PubMed ID: 22212843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairments in the STOP null mouse model of schizophrenia.
    Powell KJ; Hori SE; Leslie R; Andrieux A; Schellinck H; Thorne M; Robertson GS
    Behav Neurosci; 2007 Oct; 121(5):826-35. PubMed ID: 17907815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Schizophrenia, genetics and cognition].
    Belzeaux R; Ibrahim EC; Fakra E; Adida M; Cermolacce M; Azorin JM
    Encephale; 2011 Dec; 37 Suppl 2():S127-32. PubMed ID: 22212842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neurobiology of cognition in schizophrenia.
    Tamminga CA
    J Clin Psychiatry; 2006; 67 Suppl 9():9-13; discussion 36-42. PubMed ID: 16965183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognition in transmembrane domain neuregulin 1 mutant mice.
    Duffy L; Cappas E; Lai D; Boucher AA; Karl T
    Neuroscience; 2010 Oct; 170(3):800-7. PubMed ID: 20678553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models.
    Lyon L; Saksida LM; Bussey TJ
    Psychopharmacology (Berl); 2012 Apr; 220(4):647-72. PubMed ID: 22068459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.